drugset / Trial / NCT03986138

Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)

NCT03986138

Phase 3 Completed 324 enrolled Guerbet
RandomizedCrossoverQuadruple-blindDiagnostic

Summary

The trial aimed at evaluating the efficacy and the safety of gadopiclenol for body Magnetic resonance Imaging (MRI)

Timeline

Start
2019-08-27
Primary completion
2020-12-09
Completion
2020-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobutrol Diagnostic / imaging agent 0.1 unknown Intravenous
Subject Gadopiclenol Diagnostic / imaging agent 0.05 unknown Intravenous